Company Filing History:
Years Active: 2022-2025
Title: Bopanna Monnanda: Innovator in Vaccine Development
Introduction
Bopanna Monnanda is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of vaccine development, holding a total of 4 patents. His work focuses on synthetic saccharides that play a crucial role in the prevention and treatment of bacterial diseases.
Latest Patents
Monnanda's latest patents include a stable vaccine against various diseases. The first patent relates to a synthetic saccharide of general formula (I) that is associated with PS-II cell-surface polysaccharide and its conjugate. This invention is useful for the prevention and treatment of diseases and serves as a marker in immunological assays for detecting antibodies against bacteria. Another notable patent is for a vaccine against Klebsiella pneumoniae, which also involves a synthetic saccharide of general formula (I) related to serotype O1, O2, O2ac, and O8 O-polysaccharide. This invention is similarly beneficial for disease prevention and serves as a marker in immunological assays.
Career Highlights
Bopanna Monnanda is currently employed at Idorsia Pharmaceuticals Ltd., where he continues to innovate in the field of pharmaceuticals. His work has garnered attention for its potential impact on public health.
Collaborations
Monnanda collaborates with notable colleagues, including Arne Von Bonin and Claney Lebev Pereira. Their combined expertise contributes to the advancement of vaccine research and development.
Conclusion
Bopanna Monnanda is a key figure in the field of vaccine innovation, with a focus on synthetic saccharides that have the potential to revolutionize disease prevention and treatment. His contributions are vital to the ongoing efforts in public health and immunology.